Taku Wakabayashi

Title: Taku Wakabayashi: Innovator in Vascular Regeneration

Introduction

Taku Wakabayashi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of vascular regeneration through his innovative research and patented inventions. With a total of 2 patents, Wakabayashi is recognized for his work in developing cell populations that have potential therapeutic applications.

Latest Patents

Wakabayashi's latest patents focus on cell populations of CD31-positive, CD45-negative, CD200-positive mammalian cells and their uses. These patents provide detailed descriptions of cell populations that consist of mammalian cells positive for specific cell surface markers, including CD31 and CD200, while being negative for CD45. Additionally, he has developed a mammalian vascular endothelial stem cell that is positive for the cell surface marker CD31 and at least one of CD157 and CD200, which is also negative for CD45. His work includes the formulation of a medicament for vascular regeneration, utilizing these cell populations or vascular endothelial stem cells as active ingredients.

Career Highlights

Wakabayashi is affiliated with Osaka University, where he conducts his research and develops his inventions. His work has garnered attention in the scientific community, particularly for its implications in regenerative medicine and vascular health.

Collaborations

Wakabayashi collaborates with notable colleagues, including Nobuyuki Takakura and Hisamichi Naito. These partnerships enhance the research efforts and contribute to the advancement of their shared goals in the field of vascular regeneration.

Conclusion

Taku Wakabayashi is a key figure in the innovation of vascular regeneration, with a focus on developing cell populations that hold promise for therapeutic applications. His contributions through patents and collaborations continue to impact the field positively.